Sonanos™: A Next-Generation Injectable Excipient Enabling Sustained Release, Solubilization, and Anti-Aggregation for Challenging Modalities

Session details:

• Learn how Sonanos™ can address key formulation challenges for emerging modalities—including peptides, antibodies, proteins, and PROTACs—through a single injectable excipient platform.
• Discover how nano-sized hyaluronic acid nanogels enable sterile filtration-compatible formulations while delivering sustained release, enhanced solubilization, and anti-aggregation benefits.
• Evaluate partnership and feasibility-study opportunities around an injectable excipient platform preparing for first-in-human clinical studies, supported by proprietary manufacturing technology and planned GMP production capabilities.